Hamps Bio Becomes 2nd Most Subscribed SME IPO Of 2024; Check GMP, Allotment & Listing Details
The initial public offering of Hamps Bio Ltd. was subscribed over 1000 times on Tuesday. Here's all you need to know about the SME issue.
The initial share sale of Hamps Bio Ltd., a company engaged in the marketing and distribution of pharmaceutical products, closed for bidding on Tuesday, December 17. The IPO received a stupendous response from the investors as the issue was booked over 1000 times on the final day. In doing so, the initial public offering of Hamps Bio became the 2nd most subscribed SME IPO of 2024.
The HOAC Foods India IPO holds the top spot as the most subscribed SME IPO of 2024, achieving a massive 2,013.64 times subscription. Earlier this week, Toss The Coin IPO achieved a stellar response from investors as the SME issue became the 3rd SME IPO of 2024 to cross 1,000 times subscription.
The grey market premium (GMP) of Hamps Bio IPO soared ahead of its listing on Friday. Hamps Bio IPO GMP stood at Rs 55 as of 5:03 am on December 18, climbing from Rs 21 when the issue opened for subscription on Friday. The GMP trends have shown an upward trend since the announcement of the IPO price band.
Note: GMP or grey market price is not an official price quote for the stock and is based on speculation.
Hamps Bio IPO Day 3 Subscription Status
The IPO was subscribed 1057 times on Tuesday.
Non-Institutional Buyers: 758.27 times
Retail Investors: 1,342.04 times
Hamps Bio IPO Allotment and Listing Details
The allotment for the Hamps Bio IPO is expected to be finalised on Wednesday, December 18. Investors who bid for the issue can verify their share allotment status on BSE and Bigshare Services websites. A step-by-step guide to check allotment status can be found here.
Credit of Hamps Bio shares into the demat account of successful bidders will be done on December 19 along with initiation of refunds to non-allottees.
Shares of Hamps Bio Ltd. are expected to be listed on the BSE SME on December 20.
Hamps Bio IPO: Key Details
Hamps Bio IPO price band was fixed at Rs 51 per share, making it a fixed price issue. The Rs 6.22-crore Hamps Bio IPO (initial public offering) is an entirely fresh issue of 12.2 lakh shares. Retail investors had to buy at least 2,000 shares in one lot, taking the minimum investment amount to Rs 1,02,000.
Bigshare Services Pvt. has been appointed as registrar for the Hamps Bio IPO. Marwadi Chandarana Intermediaries Brokers Pvt. is acting as the book-running lead manager of the issue and Pure Broking is its market maker.
Hamps Bio Ltd. Business And Financials
Hamps Bio Ltd. distributes pharmaceutical products, including tablets, syrups, capsules, injectables, oil and nutritional supplements via a network of over 50 distributors and e-commerce platforms. The platforms include Amazon (US, Canada, EU), Flipkart, and Jio Mart.
The pharma products are sold in eight states and Union Territories across India. On the other hand, the freeze-dried and frozen products are distributed in six countries as well as 22 states and UTs in India.
Financials
As of the period ended October 31, the company's revenue from operations was Rs 4.26 crore, while its net profit stood at Rs 34.08 lakh. In FY24, Hamps Bio Ltd. reported a revenue of Rs 6.47 crore and a net profit of Rs 50.07 lakh.
Disclaimer: Investments in initial public offerings are subject to market risks. Please consult with financial advisors and read the red herring prospectus thoroughly before placing bids.
